Lung Cancer Chemo Response Predicted
Posted on: Wednesday, 9 May 2007, 18:00 CDT
Patients with lung cancer who will respond to chemotherapy can be identified early in the course of their treatment, say U.S. researchers.
Although we studied a relatively small number of patients -- and our results should be interpreted with caution -- it is clear that a repeat PET (Positron Emission Tomography) study with the radiotracer fluorodeoxyglucose at the end of the first cycle of chemotherapy would allow the identification of those patients for whom the therapy was futile, Claude Nahmias, of the University of Tennessee Medical Center in Knoxville, said in a statement.
The ability to provide an early indication of therapeutic response has the potential to improve patient care by identifying those patients who do not benefit from their current treatment.
The study, published in the Journal of Nuclear Medicine, reported patients would benefit from either having chemotherapy and its associated toxic side effects stopped or going on to a different therapeutic approach.
Source: United Press International
Related Articles
- Novel Therapeutic Approaches May Transform Treatment and Improve Patient Outcomes in Several Platelet Disorders
- More Than Half of Nurses Have Stopped or Delayed Patients' Chemotherapy Treatment, New Survey Shows
- Biogen Idec Leukemia Combination Regimen is Effective
- Hospitals Blamed in More Deaths
- ASTRO: Doctors Can Halve Dose of Radiation and Still Cure Hodgkin's Lymphoma
- Amgen Fights Rival for Different Uses of Drugs
- The Insidious Onset of Dyspnea and Right Lung Collapse in a 35-Year- Old Man*
- Large Community-Based Clinical Trial in Older Cancer Patients Suggests Benefits of Neulasta in First and Subsequent Cycles Of Chemotherapy
- Lung Cancer Remains Among Most Difficult to Treat
- Kemin Pharma Identifies Unique New Molecule Effective Against Human Cytomegalovirus, an Important Breakthrough for AIDS Patients, Chemotherapy Patients and Other Immunodeficient Patients
 |
 |
User Comments (0)
RSS Feeds